SEC Filing Summary

This filing details transactions made by August J. Troendle, President & CEO of Medpace Holdings, Inc. On September 25, 2026, 154 shares of Common Stock were disposed of at a price of $620.60 per share. On September 28, 2026, an additional 2410 shares of Common Stock were disposed of at a weighted average price of $620.07 per share. These transactions were part of a limit order placed during an open window period. Following these transactions, Mr. Troendle directly owns 386,892 shares. Additionally, through Medpace Investors, LLC, he may be deemed to indirectly beneficially own 4,733,019 shares of Common Stock, though he disclaims beneficial ownership beyond his pecuniary interest.